EyePoint, Inc. Payments of Debt Issuance Costs
EyePoint, Inc. (EYPT) reported Payments of Debt Issuance Costs of $1.34 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2021-03-12
- EyePoint, Inc. payments of debt issuance costs for the quarter ending 2019-12-31 was $0.00.
- EyePoint, Inc. payments of debt issuance costs for the quarter ending 2019-09-30 was $0.00.
- EyePoint, Inc. payments of debt issuance costs for the quarter ending 2019-06-30 was $447.00K, a 1.13% increase year-over-year.
- EyePoint, Inc. payments of debt issuance costs for the quarter ending 2019-03-31 was $894.00K, a 1.22% decline year-over-year.
- EyePoint, Inc. payments of debt issuance costs for fiscal 2019 was $1.34M.
- EyePoint, Inc. payments of debt issuance costs for fiscal 2018 was $1.35M.
- EyePoint, Inc. payments of debt issuance costs for fiscal 2017 was $0.00.
- EyePoint, Inc. payments of debt issuance costs for fiscal 2016 was $0.00.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $447.00K derived: sum of 3 quarters · filed 2021-03-12 | $1.34M 10-K · filed 2021-03-12 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $447.00K derived: sum of 2 quarters · filed 2020-11-06 | $1.34M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $447.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $1.34M 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $894.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $0.00 10-KT · filed 2019-03-18 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $442.00K derived: sum of 2 quarters · filed 2019-11-07 | $1.35M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $442.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.35M 10-Q · filed 2019-08-07 | $1.35M 10-K · filed 2020-03-16 | |
| 2018-03-31 | $905.00K 10-Q · filed 2019-05-10 | $905.00K 10-Q · filed 2018-05-10 | ||
| 2017-06-30 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 10-KT · filed 2019-03-18 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | |||
| 2016-06-30 | $0.00 10-KT · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |